K102471 · Mindray DS USA, Inc. · BSZ · Feb 11, 2011 · Anesthesiology
Device Facts
Record ID
K102471
Device Name
AS3700 ANESTHSIA DELIVERY SYSTEM
Applicant
Mindray DS USA, Inc.
Product Code
BSZ · Anesthesiology
Decision Date
Feb 11, 2011
Decision
SESE
Submission Type
Abbreviated
Regulation
21 CFR 868.5160
Device Class
Class 2
Attributes
Therapeutic, Pediatric
Intended Use
The AS3700 Anesthesia Delivery System is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation. The AS3700 is intended for use by licensed clinicians, for patients requiring anesthesia within a health care facility, and can be used in both adult and pediatric populations.
Device Story
AS3700 Anesthesia Delivery System; administers general inhalation anesthetics; maintains patient ventilation. Operated by licensed clinicians in health care facilities. Features 15" LCD touch screen; digital flow meters. Supports multiple ventilation modes: VCV, PCV, PCV-VG, SIMV-PC, PS. Provides default ventilation parameter settings based on patient size (adult, child, small child). Output displayed on integrated screen for clinician monitoring; assists in clinical decision-making regarding anesthesia delivery and respiratory support. Benefits patient by providing controlled anesthetic delivery and mechanical ventilation.
Clinical Evidence
Bench testing only. Compliance with safety, performance, and electromagnetic compatibility standards (IEC 60601 series, ISO 10993-1, ISO 14971, ISO 5356-1, ISO 21647, CGA V-1/V-5, ASTM F1101-90, CEN EN 980). Software verified and validated per IEC 62304. Risk analysis performed.
Technological Characteristics
15" LCD touch screen; digital flow meters. Ventilation modes: VCV, PCV, PCV-VG, SIMV-PC, PS. Standards: IEC 60601-1, 60601-1-2, 60601-1-4, 60601-1-8, 60601-2-13, IEC 62304, IEC 62366, ISO 10993-1, ISO 14971, ISO 15223, ISO 5356-1, ISO 21647, CGA V-1, CGA V-5, ASTM F1101-90, CEN EN 980. Software validated per IEC 62304.
Indications for Use
Indicated for adult and pediatric patients requiring general inhalation anesthesia and ventilation maintenance within a health care facility. Administered by licensed clinicians.
Regulatory Classification
Identification
A gas machine for anesthesia is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation. The device may include a gas flowmeter, vaporizer, ventilator, breathing circuit with bag, and emergency air supply. A gas machine for analgesia is a device used to administer to a patient an analgesic agent, such as a nitrous oxide-oxygen mixture (maximum concentration of 70 percent nitrous oxide).
K213867 — Carestation 750/750c · Datex-Ohmeda, Inc. · Mar 28, 2023
K123211 — A5 ANESTHESIA DELIVERY SYSTEM · Datascope Corp., Patient Monitoring Division · Feb 14, 2013
K132530 — GE DATEX-OHMEDA AISYS CS2 (AISYS CS^2) · Datex-Ohmeda, Inc. · Dec 20, 2013
K092864 — AESPIRE 7900, AESPIRE VIEW · Datex-Ohmeda Inc., A Division of Instrumentarium C · Jan 12, 2010
K123125 — GE DATEX-OHMEDA AVANCE CS2 · Datex-Ohmeda, Inc. · Feb 6, 2013
Submission Summary (Full Text)
{0}------------------------------------------------
# K102471 FEB 1 1 2011
## 510(k) Summary AS3700 Anesthesia Delivery System
This 510(k) Summary is provided in accordance with the requirements of 21 CFR 807.92.
| Date: | December 21, 2010 |
|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter: | Mindray DS USA, Inc.<br>800 MacArthur Blvd.<br>Mahwah, NJ 07430<br>Contact: Russell Olsen<br>Director, Quality Assurance and Regulatory Affairs<br>Telephone: 201-995-8391<br>Facsimile: 201-995-8605 |
| Device Trade Name: | AS3700 Anesthesia Delivery System |
| Common Name: | Anesthesia Delivery |
| Device Classification: | §868.1560- BSZ - Gas Machine, Anesthesia |
| Predicate Devices: | AS3000 Anesthesia Delivery System /Mindray DS USA, Inc -<br>K080175<br>Avance / GE Datex-Ohmeda - K081844 |
| Device description: | The AS3700 Anesthesia Delivery System is a device used to<br>administer to a patient, continuously or intermittently, a general<br>inhalation anesthetic and to maintain a patient's ventilation. |
| Indications for Use: | The AS3700 Anesthesia Delivery System is a device used to<br>administer to a patient, continuously or intermittently, a general<br>inhalation anesthetic and to maintain a patient's ventilation.<br>The AS3700 is intended for use by licensed clinicians, for patients<br>requiring anesthesia within a health care facility, and can be used<br>in both adult and pediatric populations. |
{1}------------------------------------------------
### Technological Comparison to Predicate Devices:
The AS3700 is equivalent to predicated devices respecting indications for use, basic operation, performance specifications and energy supply.
Relative to the predicate devices, the AS3700 incorporates a 15" LCD touch screen and the use of digital flow meters. The predicate Avance incorporates similar technology. The AS3000 support a separate display and traditional mechanical flow meters.
The AS3700 and the predicate Avance support equivalent ventilation modes: VCV, PCV, PCV, PCV- VG, SIMV-PC, SIMV- PC and PS. The predicate AS3000 supports VCV, PCV, SIMV-PC, and PS.
The AS3700 and both predicate devices are indicated for use in adult and pediatric populations. The AS3700 provides default ventilation parameter settings for adults and two pediatric populations defined as child and small child. The predicate AS3000 provides default setting for adults and the pediatric population defined as child. The predicate Avance provides default settings based on patient weight.
#### Summary of Performance Testing:
The AS3700 Anesthesia Delivery System has been tested and found to be in compliance with recognized safety, performance and electromagnetic compatibility standards.
A risk analysis has been developed to identify potential hazards and document the mitigation of the hazards. The device's software has been verified and validated in accordance with the appropriate test requirements.
The AS3700 has been tested and found to be in compliance with the following safety, performance and electromagnet compatibility standards:
- IEC 60601-1:1988+A1:1991+A2:1995 .
- IEC 60601-1-2:2007 .
- IEC 60601-1-4:2000 .
- IEC 60601-1-8:2006 ●
- IEC 60601-2-13:2003 .
- IEC 62304: 2006 o
{2}------------------------------------------------
- IEC 62366:2007 .
- ISO10993-1: 2003 .
- ISO 14971:2007 .
- ISO 15223:2000 .
- ISO 5356-1:2004 .
- ISO 21647:2004 .
- CGA V-1:2005 .
- CGA V-5:2008 .
- ASTM F1101-90:2003 .
- CEN EN 980:1996 +A1:1999+A2:2001 .
Conclusion:
Based on the description, technological comparison, performance testing and the supporting documentation, the AS3700 Anesthesia Delivery System is considered substantially equivalent to the predicate devices.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with three lines representing its body and wings. The eagle is facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Mr. Russell Olsen Vice President, Quality Assurance and Regulatory Affairs Mindray DS USA, Incorporated 800 MacArthur Boulevard Mahwah, New Jersey 07430
FEB 1 1 201
Re: K102471
Trade/Device Name: AS3700 Anesthesia Delivery System Regulation Number: 21 CFR 868.5160 Regulation Name: Gas Machine for Anesthesia or Analgesia Regulatory Class: II Product Code: BSZ Dated: February 10, 2011 Received: February 11, 2011
Dear Mr. Olsen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
Page 2 - Mr. Olsen
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
for
Anthony Watson, B.S., M.S., M.B.A. Director
Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
## Indications for Use
510(k) Number (if known):
Device Name:__________________________________________________________________________________________________________________________________________________________________
Indications For Use:
The AS3700 Anesthesia Delivery System is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation.
The AS3700 is intended for use by licensed clinicians, for patients requiring anesthesia within a health care facility, and can be used in both adult and pediatric populations.
ਮ Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Anesthesiology, General Hospital
Infection Control, Dental Devices
Page 1 of 1
K102471
510(k) Number:
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.